Legal & General Group Plc Makes New $333.59 Million Investment in Celestica, Inc. $CLS

Legal & General Group Plc bought a new position in shares of Celestica, Inc. (NYSE:CLSFree Report) (TSE:CLS) during the 2nd quarter, HoldingsChannel.com reports. The institutional investor bought 914,970 shares of the technology company’s stock, valued at approximately $333,588,000.

Other institutional investors have also recently modified their holdings of the company. The Manufacturers Life Insurance Company purchased a new position in shares of Celestica in the 2nd quarter valued at about $351,717,000. Fiduciary Financial Advisors purchased a new position in Celestica during the second quarter worth approximately $223,000. Vega Investment Solutions purchased a new position in Celestica during the second quarter worth approximately $452,000. Visionary Wealth Advisors acquired a new stake in Celestica in the second quarter valued at approximately $472,000. Finally, Tairen Capital Ltd acquired a new stake in Celestica in the second quarter valued at approximately $39,398,000. 67.38% of the stock is currently owned by institutional investors and hedge funds.

Insiders Place Their Bets

In other news, CFO Mandeep Chawla sold 16,117 shares of the business’s stock in a transaction dated Tuesday, August 4th. The shares were sold at an average price of $369.32, for a total transaction of $5,952,330.44. Following the transaction, the chief financial officer owned 65,444 shares of the company’s stock, valued at approximately $24,169,778.08. The trade was a 19.76% decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, CEO Robert Mionis sold 23,496 shares of the company’s stock in a transaction dated Thursday, August 13th. The shares were sold at an average price of $362.39, for a total transaction of $8,514,715.44. Following the completion of the sale, the chief executive officer directly owned 23,396 shares of the company’s stock, valued at $8,478,476.44. This represents a 50.11% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 356,553 shares of company stock valued at $135,238,444 over the last ninety days. Corporate insiders own 1.10% of the company’s stock.

Celestica Trading Up 4.2%

Shares of Celestica stock opened at $306.89 on Wednesday. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.23 and a quick ratio of 0.68. The stock’s 50 day simple moving average is $337.47 and its 200-day simple moving average is $335.71. The stock has a market cap of $35.29 billion, a P/E ratio of 31.90 and a beta of 2.06. Celestica, Inc. has a 1-year low of $183.66 and a 1-year high of $474.02.

Celestica (NYSE:CLSGet Free Report) (TSE:CLS) last posted its quarterly earnings results on Monday, July 27th. The technology company reported $2.54 EPS for the quarter, beating the consensus estimate of $2.29 by $0.25. Celestica had a return on equity of 39.96% and a net margin of 7.16%.The firm had revenue of $4.68 billion during the quarter, compared to analysts’ expectations of $4.30 billion. During the same quarter last year, the firm earned $1.39 earnings per share. The business’s revenue for the quarter was up 62.4% on a year-over-year basis. Celestica has set its FY 2026 guidance at 11.300-11.300 EPS and its Q3 2026 guidance at 2.880-3.080 EPS. Analysts predict that Celestica, Inc. will post 10.15 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

Several analysts have recently issued reports on the stock. Scotiabank assumed coverage on shares of Celestica in a research report on Tuesday, August 11th. They issued a “sector outperform” rating and a $500.00 target price on the stock. Citigroup lifted their price target on Celestica from $338.00 to $415.00 and gave the stock a “buy” rating in a research note on Wednesday, April 29th. Wolfe Research increased their price objective on Celestica from $425.00 to $475.00 and gave the company an “outperform” rating in a research note on Wednesday, July 29th. Royal Bank Of Canada raised their price objective on Celestica from $440.00 to $450.00 and gave the company an “outperform” rating in a report on Wednesday, July 29th. Finally, JPMorgan Chase & Co. lifted their target price on shares of Celestica from $445.00 to $485.00 and gave the stock an “overweight” rating in a research note on Wednesday, July 29th. One equities research analyst has rated the stock with a Strong Buy rating, twenty-one have assigned a Buy rating and one has issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Buy” and an average target price of $439.81.

Get Our Latest Report on CLS

Celestica Profile

(Free Report)

Celestica Inc is a multinational electronics manufacturing services (EMS) company that provides design, engineering, manufacturing and supply chain solutions to original equipment manufacturers across a range of industries. Headquartered in Toronto, Ontario, Canada, Celestica works with customers to develop and produce complex electronic and electro-mechanical products, integrating activities from product design and prototyping through high-volume assembly, testing and final system integration.

The company’s service offering typically includes product engineering and design support, printed circuit board assembly, box-build and systems assembly, automated test and inspection, aftermarket repair and refurbishment, and end-to-end supply chain and logistics management.

Read More

Want to see what other hedge funds are holding CLS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Celestica, Inc. (NYSE:CLSFree Report) (TSE:CLS).

Institutional Ownership by Quarter for Celestica (NYSE:CLS)

Receive News & Ratings for Celestica Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Celestica and related companies with MarketBeat.com's FREE daily email newsletter.